» Articles » PMID: 37723571

Longitudinal Trajectories of Atherogenic Index of Plasma and Risks of Cardiovascular Diseases: Results from the Korean Genome and Epidemiology Study

Overview
Journal Thromb J
Publisher Biomed Central
Date 2023 Sep 18
PMID 37723571
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Although the atherogenic index of plasma (AIP) based on a single measurement is a known risk factor for cardiovascular disease (CVD), little is known about whether changes in AIP over time are related to incident CVD. We aimed to determine whether AIP trajectory, which reflects homogenous AIP trends for a particular period, is associated with CVD risk.

Methods: Data from 5,843 participants of the Korean Genome and Epidemiology Study (KoGES) were analyzed. The KoGES had been conducted biennially from the baseline survey (2001-2002) to the eighth follow-up survey (2017-2018). The research design specifies the exposure period from baseline to the third follow-up, designates the latent period at the fourth follow-up, and establishes the event accrual period from the fifth to the eighth follow-up. During the exposure period, we identified two trajectories: a decreasing (n = 3,036) and an increasing group (n = 2,807) using latent variable mixture modeling. Information on CVD was collected initially through the self-reporting, followed by in depth person-to-person interview conducted by a well-trained examiner. During the event accrual period, the cumulative incidence rates of CVD between the two AIP trajectory groups were estimated using Kaplan-Meier analysis with the log-rank test. Multiple Cox proportional hazard models were used to estimate hazard ratios (HRs) and 95% confidence intervals (CIs).

Results: The increasing AIP trajectory group had a significantly higher cumulative incidence rate of CVD than the decreasing AIP trajectory group. Compared to the decreasing AIP trajectory group, the increasing AIP trajectory group had a higher risk of incident CVD (HR: 1.31, 95% CI: 1.02-1.69) after adjusting for confounders.

Conclusions: The risk of incident CVD increased when the AIP level showed an increasing trend and remained high over a long period. This suggests that checking and managing the trajectory of the AIP can be a preventive strategy for incident CVD.

Citing Articles

Relationship between plasma atherogenic index and incidence of cardiovascular diseases in Chinese middle-aged and elderly people.

Zhao M, Xiao M, Zhang H, Tan Q, Ji J, Cheng Y Sci Rep. 2025; 15(1):8775.

PMID: 40082452 PMC: 11906849. DOI: 10.1038/s41598-025-86213-6.


Association between Life's Essential 8 and Atherogenic Index of Plasma in adults: insights from NHANES 2007-2018.

Xu L, Ding K, Yang G, Han X, Cong X, Wang R Front Endocrinol (Lausanne). 2025; 16:1506884.

PMID: 40041283 PMC: 11876005. DOI: 10.3389/fendo.2025.1506884.


Atherogenic index of plasma and cardiovascular disease risk in cardiovascular-kidney-metabolic syndrome stage 1 to 3: a longitudinal study.

Zhang Y, Song Y, Lu Y, Liu T, Yin P Front Endocrinol (Lausanne). 2025; 16:1517658.

PMID: 39968297 PMC: 11832398. DOI: 10.3389/fendo.2025.1517658.


Baseline atherogenic index of plasma and its trajectory predict onset of type 2 diabetes in a health screened adult population: a large longitudinal study.

Sun Y, Lin X, Zou Z, Zhao C, Liu A, Zhou J Cardiovasc Diabetol. 2025; 24(1):57.

PMID: 39920728 PMC: 11806864. DOI: 10.1186/s12933-025-02619-6.

References
1.
Roth G, Mensah G, Johnson C, Addolorato G, Ammirati E, Baddour L . Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019: Update From the GBD 2019 Study. J Am Coll Cardiol. 2020; 76(25):2982-3021. PMC: 7755038. DOI: 10.1016/j.jacc.2020.11.010. View

2.
Kim H . Epidemiology of cardiovascular disease and its risk factors in Korea. Glob Health Med. 2021; 3(3):134-141. PMC: 8239378. DOI: 10.35772/ghm.2021.01008. View

3.
Beaglehole R, Bonita R, Horton R, Adams C, Alleyne G, Asaria P . Priority actions for the non-communicable disease crisis. Lancet. 2011; 377(9775):1438-47. DOI: 10.1016/S0140-6736(11)60393-0. View

4.
Gheorghe A, Griffiths U, Murphy A, Legido-Quigley H, Lamptey P, Perel P . The economic burden of cardiovascular disease and hypertension in low- and middle-income countries: a systematic review. BMC Public Health. 2018; 18(1):975. PMC: 6090747. DOI: 10.1186/s12889-018-5806-x. View

5.
Magnus P, Beaglehole R . The real contribution of the major risk factors to the coronary epidemics: time to end the "only-50%" myth. Arch Intern Med. 2001; 161(22):2657-60. DOI: 10.1001/archinte.161.22.2657. View